Page last updated: 2024-11-07

quillaic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Quillaic acid is a triterpenoid saponin, a naturally occurring compound found in the bark of the Quillaja saponaria tree, also known as the soapbark tree. This compound has a complex structure, with a triterpene aglycone (the non-sugar portion) attached to multiple sugar molecules (glycones). It is known for its potent foaming properties, hence the common name soapbark. Due to its diverse biological activities, quillaic acid has been extensively researched for various applications. It exhibits immunostimulatory properties, stimulating the immune system by activating macrophages and lymphocytes. This has led to its investigation as an adjuvant in vaccines, enhancing their efficacy. It also has antiviral activity against several viruses, including HIV and influenza. Additionally, quillaic acid has shown promise as an anti-cancer agent, demonstrating cytotoxic effects against various cancer cell lines. Its ability to disrupt cell membranes and induce apoptosis (programmed cell death) is attributed to its saponin structure. Furthermore, quillaic acid has been explored for its potential in drug delivery, acting as a carrier molecule to enhance the absorption and bioavailability of other drugs. The unique properties of quillaic acid, including its foaming capabilities, immunostimulatory effects, antiviral activity, and anticancer potential, have made it an intriguing subject of scientific study. '

quillaic acid : A pentacyclic triterpenoid that is olean-12-ene substituted by hydroxy groups at positions 3 and 16, an oxo group at position 23 and a carboxy group at position 28 (the 3beta,16alpha stereoisomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID101810
CHEMBL ID260060
CHEBI ID8710
SCHEMBL ID867115
MeSH IDM0047199

Synonyms (29)

Synonym
quillaic acid
631-01-6
C08972
CHEMBL260060
chebi:8710 ,
(4ar,5r,6ar,6as,6br,8ar,9s,10s,12ar,14bs)-9-formyl-5,10-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
(3beta,16alpha)-3,16-dihydroxy-23-oxoolean-12-en-28-oic acid
einecs 211-149-8
69o8e4g02b ,
unii-69o8e4g02b
(3beta,4alpha,16alpha)-3,16-dihydroxy-23-oxoolean-12-en-28-oic acid
quillaic acid [mi]
olean-12-en-28-oic acid, 3.beta.,16.alpha.-dihydroxy-23-oxo-
(+)-quillaic acid
olean-12-en-28-oic acid, 3,16-dihydroxy-23-oxo-, (3.beta.,4.alpha.,16.alpha.)-
S9019
SCHEMBL867115
HY-N0839
3beta,16alpha-dihydroxy-23-oxoolean-12-en-28-oic acid
LMPR0106150037
(4ar,5r,6as,6br,8ar,9s,10s,12ar,12br,14bs)-9-formyl-5,10-dihydroxy-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2h)-carboxylic acid
quillaic acid(quillaja sapogenin)
mfcd22479218
AKOS032949114
AS-35340
Q27108137
CCG-269595
A868243
DTXSID001026576
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
anti-inflammatory agentAny compound that has anti-inflammatory effects.
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
pentacyclic triterpenoid
hydroxy monocarboxylic acidAny monocarboxylic acid which also contains a separate (alcoholic or phenolic) hydroxy substituent.
aldehydeA compound RC(=O)H, in which a carbonyl group is bonded to one hydrogen atom and to one R group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID750465Antiviral activity against pseudo VSV infected in human 293T cells assessed as inhibition of vesicular stromatis G protein pseudo particles entry at 1 uM after 72 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
AID750467Antiviral activity against pseudo HCV infected in human 293T cells assessed as inhibition of HCV pseudo particles entry at 1 uM after 72 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
AID750464Antiviral activity against pseudo VSV infected in human 293T cells assessed as inhibition of vesicular stromatis G protein pseudo particles entry at 5 uM after 72 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
AID323184Inhibition of Gypsophila oldhamiana alpha-glucosidase2008Bioorganic & medicinal chemistry, Mar-15, Volume: 16, Issue:6
New triterpenoid saponins with strong alpha-glucosidase inhibitory activity from the roots of Gypsophila oldhamiana.
AID750462Antiviral activity against pseudo HCV infected in human 293T cells assessed as inhibition of HCV pseudo particles entry at 10 uM after 72 hrs by luciferase reporter gene assay2013Journal of medicinal chemistry, Jun-13, Volume: 56, Issue:11
Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (22.73)18.2507
2000's9 (40.91)29.6817
2010's7 (31.82)24.3611
2020's1 (4.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.55 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (13.04%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (86.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]